AbbVie is reaching for the Sky(rizi) as it spent a staggering $51.5 million on TV drug ads for its immunology blockbuster in October. | AbbVie is reaching for the Sky(rizi) as it spent a staggering ...
2h
Johnson & Johnson (NYSE: JNJ) announced today that 43 presentations showcasing the Company's rheumatology pipeline and portfolio will be featured at the American College of Rheumatology (ACR) 2024 ...
RYTELOâ„¢ (imetelstat) is FDA approved for the treatment of low- to intermediate-1 risk myelodysplastic syndromes with transfusion-dependent ...
Significant contributors to Royalty Pharma’s financial success include strong performances from Trelegy, Evrysdi, and Tremfya, alongside strategic acquisitions of synthetic royalties for therapies ...
Results from a retrospective cohort study show lower all-cause mortality and fewer hospitalizations and intestinal ...
Amid current economic uncertainties and market volatility, investing in defensive stocks appears as an ideal strategy for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback